NCT06560749

Brief Summary

The goal of this clinical trial is to evaluate the impact of Physical Exercise (PE), as an adjuvant treatment, on the cognition of patients diagnosed with Bipolar Disorder who present cognitive impairments, as well as its impact on quality of life and functionality and its association with physiological variables. Our specific goals are:

  1. 1.Evaluate the effect of PE on the neuropsychological functions of attention, memory, verbal fluency, executive function and processing speed in patients diagnosed with BD who present cognitive impairments in these domains.
  2. 2.To evaluate the effect of PE on the quality of life and functionality of patients diagnosed with BD, as well as possible associations with cognitive functions.
  3. 3.To evaluate possible correlations between physiological variables, such as cardiorespiratory indices, strength and body composition, and improvements in cognitive functions, quality of life and functionality.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Aug 2024Aug 2026

First Submitted

Initial submission to the registry

August 13, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 19, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

August 20, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

August 19, 2024

Status Verified

August 1, 2024

Enrollment Period

12 months

First QC Date

August 13, 2024

Last Update Submit

August 16, 2024

Conditions

Keywords

Bipolar Disorder

Outcome Measures

Primary Outcomes (20)

  • Montgomery-Asberg Depression Rating Scale (MADRS)

    Scale used to assess the presence and intensity of depressive symptoms.

    Baseline, Week 4, Week 8 and Follow-up (12 weeks)

  • Young Mania Rating Scale (YMRS)

    Scale used to assess the presence and intensity of manic symptoms.

    Baseline, Week 4, Week 8 and Follow-up (12 weeks)

  • Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA)

    Screening scale for the presence of cognitive deficits. Suggested cutoff point is 14

    Baseline only

  • Screen for Cognitive Impairment in Psychiatry (SCIP)

    Subjective screening scale for difficulties associated with cognitive impairment. Suggested cutoff point is 70

    Baseline only

  • Stroop Color-Word Test (Spreen and Strauss, 1998)

    Assessing mental flexibility and inhibitory control (attention and executive function)

    Baseline and Follow-up (12 weeks)

  • Verbal Fluency - F.A.S (Spreen and Strauss, 1998)

    Assessing verbal fluency, inhibitory control and the correct use of strategies (executive function)

    Baseline and Follow-up (12 weeks)

  • Trail Making Test (Spreen and Strauss, 1998)

    Assessing alternating attention

    Baseline and Follow-up (12 weeks)

  • Logical Memory I and II (Wechsler, 1997b)

    Assessing verbal memory

    Baseline and Follow-up (12 weeks)

  • List of Words (Wechsler, 1997a)

    Assessing learning capacity and attention

    Baseline and Follow-up (12 weeks)

  • Cardiovascular evaluation

    All patients will undergo an electrocardiogram computerized.

    Baseline and Follow-up (12 weeks)

  • Stress test on the treadmill

    A treadmill stress test will be performed.

    Baseline and Follow-up (12 weeks)

  • Respiratory gas exchange analysis (ergospirometric)

    A computerized gas exchange analysis system will be used (CPX/ULTIMA, Medgraphics®, Saint Paul, MN, USA)

    Baseline and Follow-up (12 weeks)

  • Isokinetic Strength Test

    The isokinetic test will be performed on the lower limbs (extensor and flexor muscles of the knee joints) on the dominant (R) and non-dominant (ND) leg at an angular velocity of 60 s -1 using a computerized isokinetic dynamometer (Biodex®, Inc . USA).

    Baseline and Follow-up (12 weeks)

  • Body composition by bioimpedance

    Body composition measurements will be obtained by the non-invasive indirect bioimpedance method using a scale

    Baseline and Follow-up (12 weeks)

  • Anthropometric measurements (skinfolds) and calculation of body composition

    Body mass (BM) will be measured on a Filizola mechanical scale, with an accuracy of 0.1 kg. Height will be determined using a stadiometer, attached to the scale, with an accuracy of 0.1cm (Gordon et al., 1988). Body composition will be determined using the skinfold thickness technique.

    Baseline and Follow-up (12 weeks)

  • One Repetition Maximum Test (1RM)

    The exercises to be tested are the seated bench press (pectoral muscles), leg-press (quadriceps and glutes), rowing (dorsal muscles), standing knee bending chair (hamstrings), abdominal (rectus and abdominal obliques).

    Baseline and Follow-up (12 weeks)

  • Wechsler Abbreviated Scale of Intelligence (WASI)

    delivers an estimation of a student's general intellectual ability by measuring the verbal, nonverbal, and general cognition of individuals from 6 to 89 years of age.

    Baseline and Follow-up (12 weeks)

  • Digit Span Memory Test

    short test that evaluates a person's memory and cognitive status

    Baseline and Follow-up (12 weeks)

  • Cognitive Emotion Regulation Questionnaire (CERQ)

    Questionnaire measuring cognitive coping strategies

    Baseline and Follow-up (12 weeks)

  • Difficulties in Emotion Regulation Scale (DERS)

    Instrument measuring emotion regulation problems

    Baseline and Follow-up (12 weeks)

Secondary Outcomes (2)

  • Functional Assessment Staging Tool (FAST)

    Baseline and Follow-up (12 weeks)

  • The World Health Organization Quality of Life Assessment (WHOQOL)

    Baseline and Follow-up (12 weeks)

Study Arms (2)

Intervention Group

EXPERIMENTAL

The experimental group will be submitted to supervised training sessions, three times per week, for 12 weeks, of aerobics exercises, as well as treatment as usual (TAU)

Other: Physical Exercise

Control Group

NO INTERVENTION

the control group will be submitted exclusively to treatment as usual (TAU)

Interventions

Measure the impact of physical exercise in the cognition of pacients diagnosed with Bipolar Disorder

Intervention Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of Bipolar disorder (BD) I and II according to DSM-5
  • Age: 18 - 55 years old
  • Complete primary education
  • Euthymic (YMRS \< 8 and MADRS \< 12)
  • Presence of cognitive impairments (COBRA \> 14 and SCIP \< 75)
  • Estimated IQ ≥ 80
  • No medication changes in the last month
  • Having been without regular PE practice for six months
  • Signature of the TCLE

You may not qualify if:

  • Organic mental disorder
  • BMI \> 40
  • Alcohol or drug abuse in the last 6 months
  • Use of benzodiazepines or beta-blockers in the last month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gabriel Okawa Belizario

São Paulo, São Paulo, 05403-903, Brazil

RECRUITING

MeSH Terms

Conditions

Bipolar Disorder

Interventions

Exercise

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Beny Lafer, M.D, Ph.D

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Beny Lafer, M.D, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal INvestigator

Study Record Dates

First Submitted

August 13, 2024

First Posted

August 19, 2024

Study Start

August 20, 2024

Primary Completion

August 1, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

August 19, 2024

Record last verified: 2024-08

Locations